Literature DB >> 8282805

Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis.

H Rakugi1, D K Kim, J E Krieger, D S Wang, V J Dzau, R E Pratt.   

Abstract

Angiotensin II (Ang II) promotes growth of vascular smooth muscle cells in vitro. Consistent with this, Ang II enhances neointimal proliferation in vivo after vascular injury, while angiotensin converting enzyme (ACE) inhibitors attenuate this process. Since tissue ACE plays a key role in the control of local Ang II production, we examined whether vascular injury resulted in an increase in vascular ACE expression that may result in increased Ang II production. Abdominal aorta of Sprague-Dawley rats were injured with a 2 French balloon catheter. Morphometrical changes, ACE enzymatic activity, and localization of ACE by immunohistochemistry in injured and uninjured aorta were analyzed. Vascular ACE activity in the injured aorta was significantly higher than in the uninjured aorta, while serum and lung ACE levels were not different between the two groups. The cellular distribution of the ACE protein in the neointima was similar to that of alpha smooth muscle actin but differed from those of endothelial (von Willebrand factor) or monocytes/macrophages (ED-1) markers, demonstrating that ACE was expressed in neointimal smooth muscle cells. These data demonstrate that vascular injury results in the induction of vascular ACE and suggest that the inhibition of vascular ACE may be important in the prevention of restenosis after balloon injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8282805      PMCID: PMC293775          DOI: 10.1172/JCI116965

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Effects of an angiotensin-converting enzyme (ACE) inhibitor, SA446, on tissue ACE activity in normotensive, spontaneously hypertensive, and renal hypertensive rats.

Authors:  K Nakata; K Nishimura; T Takada; T Ikuse; H Yamauchi; T Iso
Journal:  J Cardiovasc Pharmacol       Date:  1987-03       Impact factor: 3.105

2.  Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca.

Authors:  H S Cheung; D W Cushman
Journal:  Biochim Biophys Acta       Date:  1973-02-15

3.  Superficial intimal injury of the rabbit carotid artery induced by distilled water.

Authors:  A Tanimura; S Tanaka; M Kitazono
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1986

4.  The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3.

Authors:  C D Dijkstra; E A Döpp; P Joling; G Kraal
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

5.  Rapid affinity chromatographic purification of human lung and kidney angiotensin-converting enzyme with the novel N-carboxyalkyl dipeptide inhibitor N-[1(S)-carboxy-5-aminopentyl]glycylglycine.

Authors:  M R Ehlers; D L Maeder; R E Kirsch
Journal:  Biochim Biophys Acta       Date:  1986-09-04

6.  Monoclonal antibody against angiotensin-converting enzyme: its use as a marker for murine, bovine, and human endothelial cells.

Authors:  R Auerbach; L Alby; J Grieves; J Joseph; C Lindgren; L W Morrissey; Y A Sidky; M Tu; S L Watt
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

7.  Early and late morphologic changes in major epicardial coronary arteries after percutaneous transluminal coronary angioplasty.

Authors:  B F Waller; H J Gorfinkel; F J Rogers; K M Kent; W C Roberts
Journal:  Am J Cardiol       Date:  1984-06-15       Impact factor: 2.778

8.  Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells.

Authors:  M W Majesky; E P Benditt; S M Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

9.  Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.

Authors:  A A Geisterfer; M J Peach; G K Owens
Journal:  Circ Res       Date:  1988-04       Impact factor: 17.367

10.  Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled.

Authors:  G de Nucci; R J Gryglewski; T D Warner; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

View more
  31 in total

Review 1.  New developments in endovascular interventions for extracranial carotid stenosis.

Authors:  W A Tan; C R Jarmolowski; L R Wechsler; M H Wholey
Journal:  Tex Heart Inst J       Date:  2000

2.  Gradual reactivation of vascular angiotensin I to angiotensin II conversion during chronic ACE inhibitor therapy in patients with diabetes mellitus.

Authors:  D C Sharman; A D Morris; A D Struthers
Journal:  Diabetologia       Date:  2007-08-04       Impact factor: 10.122

3.  Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass.

Authors:  H Schunkert; H W Hense; M Muscholl; A Luchner; S Kürzinger; A H Danser; G A Riegger
Journal:  Heart       Date:  1997-01       Impact factor: 5.994

Review 4.  Role of the renin-angiotensin system in the pathogenesis of intimal hyperplasia: therapeutic potential for prevention of vein graft failure?

Authors:  Michael J Osgood; David G Harrison; Kevin W Sexton; Kyle M Hocking; Igor V Voskresensky; Padmini Komalavilas; Joyce Cheung-Flynn; Raul J Guzman; Colleen M Brophy
Journal:  Ann Vasc Surg       Date:  2012-03-22       Impact factor: 1.466

5.  Effects of angiotensin I and angiotensin II in blood vessels: greater influence of converting enzyme activity in the rabbit basilar artery.

Authors:  A Zerrouk; M Auguet; S Delaflotte; P E Chabrier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

6.  Increased expression and co-localization of ACE, angiotensin II AT(1) receptors and inducible nitric oxide synthase in atherosclerotic human coronary arteries.

Authors:  Mitsuru Ohishi; Gregory J Dusting; Paul A Fennessy; Frederick Ao Mendelsohn; Xiao C Li; Jia L Zhuo
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-04-30

7.  Angiotensin-converting enzyme gene insertion/deletion polymorphism in Korean patients with systemic sclerosis.

Authors:  Chung Il Joung; Yong Wook Park; Sook Kyoung Kim; Wan Sik Uhm; Tae Hwan Kim; Dae Hyun Yoo
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

8.  ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis.

Authors:  M A Hernández-Presa; C Bustos; M Ortego; J Tuñón; L Ortega; J Egido
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

9.  Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme.

Authors:  R Morishita; G H Gibbons; K E Ellison; W Lee; L Zhang; H Yu; Y Kaneda; T Ogihara; V J Dzau
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

10.  The effect of angiotensin II on the proliferation of human gingival fibroblasts.

Authors:  Hidenori Oguro; Kohzo Tsuchikawa
Journal:  Odontology       Date:  2009-07-29       Impact factor: 2.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.